Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-03-03 @ 12:21 PM
Study NCT ID:
NCT05569720
Status:
COMPLETED
Last Update Posted:
2022-10-06
First Post:
2022-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Study to Compare Safety Between Intravenous Bolus Versus Infusion of ApTOLL
Sponsor:
aptaTargets S.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-28
First Submit QC Date:
None
Study First Post Date:
2022-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-05
Last Update Post Date:
2022-10-06
Last Update Post Date Type:
ACTUAL